The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dubois, P. M.
Right arrow Articles by Marvel, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dubois, P. M.
Right arrow Articles by Marvel, J.
The Journal of Immunology, 1998, 161: 5260-5267.
Copyright © 1998 by The American Association of Immunologists

Tolerant CD8 T Cells Induced by Multiple Injections of Peptide Antigen Show Impaired TCR Signaling and Altered Proliferative Responses In Vitro and In Vivo1

Patrice M. Dubois2,*, Maria Pihlgren*, Martine Tomkowiak*, Marcelle Van Mechelen{dagger} and Jacqueline Marvel*

* Immunologie Cellulaire, Laboratoire de Biologie Moléculaire et Cellulaire, Ecole Normale Supérieure de Lyon Centre National de la Recherche Scientifique, Lyon, France; and {dagger} Laboratoire de Physiologie Animale, Université Libre de Bruxelles, Brussels, Belgium

The mechanisms responsible for peripheral CD8 T cell tolerance to foreign Ags remain poorly understood. In this study we have characterized the state of CD8 T cell tolerance induced in F5 TCR transgenic mice by multiple peptide injections in vivo. The tolerant state of CD8 T cells is characterized by impaired proliferative responses, increased sensitivity to cell death, and failure to acquire cytotoxic effector function after in vitro antigenic challenge. In vivo monitoring of CD8 T cell proliferation using 5-carboxyfluorescein diacetate succinimidyl ester showed that a large subset of the tolerant T cell population failed to divide in response to peptide. TCR down-regulation could not account for this loss of responsiveness to Ag since recombination-activating gene-1 (RAG-1)-/-F5 CD8 T cell responses were similar to those of RAG-1-/-F5 x RAG-1-/- F1 T lymphocytes, which express lower levels of the transgenic TCR. Analysis of early signal transduction in tolerant CD8 T cells revealed high basal levels of cytoplasmic calcium as well as impaired calcium mobilization and tyrosine phosphorylation after cross-linking of CD3{epsilon} and CD8{alpha}. Together these data indicate that repeated exposure to soluble antigenic peptide in vivo can induce a state of functional tolerance characterized by defective TCR signaling, impaired proliferation, and increased sensitivity to cell death.




This article has been cited by other articles:


Home page
J. Immunol.Home page
C. D. Hammerbeck and M. F. Mescher
Antigen Controls IL-7R{alpha} Expression Levels on CD8 T Cells during Full Activation or Tolerance Induction
J. Immunol., February 15, 2008; 180(4): 2107 - 2116.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Srinivasan and K. A. Frauwirth
Reciprocal NFAT1 and NFAT2 Nuclear Localization in CD8+ Anergic T Cells Is Regulated by Suboptimal Calcium Signaling
J. Immunol., September 15, 2007; 179(6): 3734 - 3741.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Pihlgren, M. Friedli, C. Tougne, A.-F. Rochat, P.-H. Lambert, and C.-A. Siegrist
Reduced Ability of Neonatal and Early-Life Bone Marrow Stromal Cells to Support Plasmablast Survival
J. Immunol., January 1, 2006; 176(1): 165 - 172.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Ise, K. Nakamura, N. Shimizu, H. Goto, K. Fujimoto, S. Kaminogawa, and S. Hachimura
Orally Tolerized T Cells Can Form Conjugates with APCs but Are Defective in Immunological Synapse Formation
J. Immunol., July 15, 2005; 175(2): 829 - 838.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. L. Redmond, B. C. Marincek, and L. A. Sherman
Distinct Requirements for Deletion versus Anergy during CD8 T Cell Peripheral Tolerance In Vivo
J. Immunol., February 15, 2005; 174(4): 2046 - 2053.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
K. A. Mitchell and B. P. Lawrence
Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Renders Influenza Virus-Specific CD8+ T Cells Hyporesponsive to Antigen
Toxicol. Sci., July 1, 2003; 74(1): 74 - 84.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. M. Curtsinger, D. C. Lins, and M. F. Mescher
Signal 3 Determines Tolerance versus Full Activation of Naive CD8 T Cells: Dissociating Proliferation and Development of Effector Function
J. Exp. Med., May 5, 2003; 197(9): 1141 - 1151.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Asai, S. Hachimura, M. Kimura, T. Toraya, M. Yamashita, T. Nakayama, and S. Kaminogawa
T Cell Hyporesponsiveness Induced by Oral Administration of Ovalbumin Is Associated with Impaired NFAT Nuclear Translocation and p27kip1 Degradation
J. Immunol., November 1, 2002; 169(9): 4723 - 4731.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C. Ohlen, M. Kalos, L. E. Cheng, A. C. Shur, D. J. Hong, B. D. Carson, N. C.T. Kokot, C. G. Lerner, B. D. Sather, E. S. Huseby, et al.
CD8+ T Cell Tolerance to a Tumor-associated Antigen Is Maintained at the Level of Expansion Rather than Effector Function
J. Exp. Med., June 3, 2002; 195(11): 1407 - 1418.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Steinbrink, E. Graulich, S. Kubsch, J. Knop, and A. H. Enk
CD4+ and CD8+ anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity
Blood, April 1, 2002; 99(7): 2468 - 2476.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Walzer, C. Arpin, L. Beloeil, and J. Marvel
Differential In Vivo Persistence of Two Subsets of Memory Phenotype CD8 T Cells Defined by CD44 and CD122 Expression Levels
J. Immunol., March 15, 2002; 168(6): 2704 - 2711.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Arpin, G. Angelov, T. Walzer, M. Tomkowiak, and J. Marvel
Hyperproliferative Response of a Monoclonal Memory CD8 T Cell Population Is Characterized by an Increased Frequency of Clonogenic Precursors
J. Immunol., March 1, 2002; 168(5): 2147 - 2153.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. A. Frauwirth, M.-L. Alegre, and C. B. Thompson
CTLA-4 Is Not Required for Induction of CD8+ T Cell Anergy In Vivo
J. Immunol., November 1, 2001; 167(9): 4936 - 4941.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Maile, B. Wang, W. Schooler, A. Meyer, E. J. Collins, and J. A. Frelinger
Antigen-Specific Modulation of an Immune Response by In Vivo Administration of Soluble MHC Class I Tetramers
J. Immunol., October 1, 2001; 167(7): 3708 - 3714.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Bercovici, A. Heurtier, C. Vizler, N. Pardigon, C. Cambouris, P. Desreumaux, and R. Liblau
Systemic Administration of Agonist Peptide Blocks the Progression of Spontaneous CD8-Mediated Autoimmune Diabetes in Transgenic Mice Without Bystander Damage
J. Immunol., July 1, 2000; 165(1): 202 - 210.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. A. Frauwirth, M.-L. Alegre, and C. B. Thompson
Induction of T Cell Anergy in the Absence of CTLA-4/B7 Interaction
J. Immunol., March 15, 2000; 164(6): 2987 - 2993.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. T. Nugent, D. J. Morgan, J. A. Biggs, A. Ko, I. M. Pilip, E. G. Pamer, and L. A. Sherman
Characterization of CD8+ T Lymphocytes That Persist After Peripheral Tolerance to a Self Antigen Expressed in the Pancreas
J. Immunol., January 1, 2000; 164(1): 191 - 200.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. S. Schmidt and M. F. Mescher
Adjuvant Effect of IL-12: Conversion of Peptide Antigen Administration from Tolerizing to Immunizing for CD8+ T Cells In Vivo
J. Immunol., September 1, 1999; 163(5): 2561 - 2567.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. A. Blish, S. R. Dillon, A. G. Farr, and P. J. Fink
Anergic CD8+ T Cells Can Persist and Function In Vivo
J. Immunol., July 1, 1999; 163(1): 155 - 164.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.